Combination of acute preoperative plateletpheresis, cell salvage, and aprotinin minimizes blood loss and requirement during cardiac surgery
- PMID: 15804151
- PMCID: PMC4680807
Combination of acute preoperative plateletpheresis, cell salvage, and aprotinin minimizes blood loss and requirement during cardiac surgery
Abstract
Acute preoperative plateletpheresis (APP), cell salvage (CS) technique, and the use of aprotinin have been individually reported to be effective in reducing blood loss and blood component transfusion while improving hematological profiles in patients undergoing cardiac surgery with cardiopulmonary bypass (CPB). In this prospective randomized clinical study, the efficacy of these combined approaches on reducing blood loss and transfusion requirements was evaluated. Seventy patients undergoing primary coronary artery bypass grafting (CABG) were randomly divided into four groups: a control group (group I, n = 10) did not receive any of the previously mentioned approaches. An APP and CS group (group II, n = 20) experienced APP in which preoperative platelet-rich plasma was collected and reinfused after reversal of heparin, along with the cell salvage technique throughout surgery. The third group (group III, n = 22) received aprotinin in which 5,000,000 KIU Trasylol was applied during surgery, and a combination group (group IV, n = 18) was treated with all three approaches, i.e., APP, CS, and aprotinin. Compared with group I (896+/-278 mL), the postoperative total blood loss was significantly reduced in groups II, III, and IV (468+/-136, 388+/-122, 202+/-81 mL, respectively, p < 0.05). The requirements of packed red blood cells in the three approached groups (153+/-63, 105+/-178, 0+/-0 mL, respectively) also were reduced when compared with group I (343+/-118 mL, p < 0.05). In group I, six patients (6/10) received fresh-frozen plasma and three patients (3/10) received platelet transfusion, whereas no patients in the other three groups required fresh-frozen plasma and platelet. In conclusion, both plateletpheresis concomitant with cell salvage and aprotinin contribute to the improvement of postoperative hemostasis, and the combination of these two approaches could minimize postoperative blood loss and requirement.
Conflict of interest statement
The senior author has stated that authors have reported no material, financial or other relationship with any healthcare-related business or other entity whose products or services are discussed in this paper.
Figures
Similar articles
-
Preoperative plateletpheresis does not reduce blood loss during cardiac surgery.Can J Anaesth. 1993 Sep;40(9):844-50. doi: 10.1007/BF03009256. Can J Anaesth. 1993. PMID: 8104730 Clinical Trial.
-
The influence of acute preoperative plasmapheresis on coagulation tests, fibrinolysis, blood loss and transfusion requirements in cardiac surgery.Eur J Cardiothorac Surg. 1997 Mar;11(3):557-63. doi: 10.1016/s1010-7940(96)01093-7. Eur J Cardiothorac Surg. 1997. Retraction in: Eur J Cardiothorac Surg. 2019 May 1;55(5):1024. doi: 10.1093/ejcts/ezz079. PMID: 9105824 Retracted. Clinical Trial.
-
Tranexamic acid and aprotinin in primary cardiac operations: an analysis of 220 cardiac surgical patients treated with tranexamic acid or aprotinin.Anesth Analg. 2008 Nov;107(5):1469-78. doi: 10.1213/ane.0b013e318182252b. Anesth Analg. 2008. PMID: 18931201 Clinical Trial.
-
Aprotinin. A review of its pharmacology and therapeutic efficacy in reducing blood loss associated with cardiac surgery.Drugs. 1995 Jun;49(6):954-83. doi: 10.2165/00003495-199549060-00008. Drugs. 1995. PMID: 7543841 Review.
-
Blood conservation in cardiac surgery.Ann Thorac Surg. 1990 Nov;50(5):843-51. doi: 10.1016/0003-4975(90)90707-d. Ann Thorac Surg. 1990. PMID: 2241359 Review.
Cited by
-
Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion.Cochrane Database Syst Rev. 2011 Mar 16;2011(3):CD001886. doi: 10.1002/14651858.CD001886.pub4. Cochrane Database Syst Rev. 2011. PMID: 21412876 Free PMC article.
-
A meta-analysis of platelet gel for prevention of sternal wound infections following cardiac surgery.Blood Transfus. 2017 Jan;15(1):57-65. doi: 10.2450/2016.0231-15. Epub 2016 Apr 28. Blood Transfus. 2017. PMID: 27177403 Free PMC article.
-
[Platelet collection in cardiac surgery: first experience with apheresis at the General Hospital in Douala].Pan Afr Med J. 2018 Sep 20;31:41. doi: 10.11604/pamj.2018.31.41.16571. eCollection 2018. Pan Afr Med J. 2018. PMID: 30918567 Free PMC article. French.
-
Efficacy of autologous plateletpheresis in adult aortic surgery: study protocol for a randomised controlled trial.BMJ Open. 2023 Jun 7;13(6):e073341. doi: 10.1136/bmjopen-2023-073341. BMJ Open. 2023. PMID: 37286322 Free PMC article.
References
-
- Chavez AM, Cosgrove DM.. Blood conservation. Semin Thorac Cardiovasc Surg. 1990;2:358–63. - PubMed
-
- Breyer RH, Engelman RM, Rousou JA, Lemeshow SA.. A comparison of cell saver versus ultrafilter during coronary artery bypass operations. J Thorac Cardiovasc Surg. 1985;90:736–40. - PubMed
-
- Hall RI, Schweiger IM, Finlayson DC.. The benefit of the Hemonetics cell saver apparatus during cardiac surgery. Can J Anaesth. 1990;37:618–23. - PubMed
-
- Boldt J, Kling D, Zickmann B, Jacobi M, Dapper F, Hempelmann G.. Acute preoperative plasmapheresis and established blood conservation techniques. Ann Thorac Surg. 1990;50:62–8. - PubMed
-
- Gravlee GP.. Autologous platelet-rich plasma in cardiac surgery: aesthetics versus virtue. J Cardiothorac Vasc Anesth. 1993;7:1–3. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical